98 related articles for article (PubMed ID: 28032764)
1. Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry.
Wang Y; Zhu J; Zhang L
J Med Chem; 2017 Jan; 60(1):263-272. PubMed ID: 28032764
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Low Toxicity O-GlcNAc Transferase (OGT) Inhibitor by Structure-based Virtual Screening of Natural Products.
Liu Y; Ren Y; Cao Y; Huang H; Wu Q; Li W; Wu S; Zhang J
Sci Rep; 2017 Sep; 7(1):12334. PubMed ID: 28951553
[TBL] [Abstract][Full Text] [Related]
3. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
5. Discovery of O-GlcNAc transferase inhibitors.
Gross BJ; Kraybill BC; Walker S
J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin SES; Tan ZW; Itkonen HM; Duveau DY; Paulo JA; Janetzko J; Boutz PL; Törk L; Moss FA; Thomas CJ; Gygi SP; Lazarus MB; Walker S
J Am Chem Soc; 2018 Oct; 140(42):13542-13545. PubMed ID: 30285435
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
[TBL] [Abstract][Full Text] [Related]
10. o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells.
Song M; Kim HS; Park JM; Kim SH; Kim IH; Ryu SH; Suh PG
Cell Signal; 2008 Jan; 20(1):94-104. PubMed ID: 18029144
[TBL] [Abstract][Full Text] [Related]
11. Label-free electrochemical biosensing of small-molecule inhibition on O-GlcNAc glycosylation.
Yang Y; Gu Y; Wan B; Ren X; Guo LH
Biosens Bioelectron; 2017 Sep; 95():94-99. PubMed ID: 28427012
[TBL] [Abstract][Full Text] [Related]
12. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
13. Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray.
Shi J; Sharif S; Ruijtenbeek R; Pieters RJ
PLoS One; 2016; 11(3):e0151085. PubMed ID: 26960196
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
[TBL] [Abstract][Full Text] [Related]
15. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of O-GlcNAcase inhibitors via 'click chemistry' and biological evaluations.
Li T; Guo L; Zhang Y; Wang J; Li Z; Lin L; Zhang Z; Li L; Lin J; Zhao W; Li J; Wang PG
Carbohydr Res; 2011 Jul; 346(9):1083-92. PubMed ID: 21514574
[TBL] [Abstract][Full Text] [Related]
17. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
[TBL] [Abstract][Full Text] [Related]
18. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
19. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
[TBL] [Abstract][Full Text] [Related]
20. Targeted covalent inhibition of O-GlcNAc transferase in cells.
Worth M; Hu CW; Li H; Fan D; Estevez A; Zhu D; Wang A; Jiang J
Chem Commun (Camb); 2019 Oct; 55(88):13291-13294. PubMed ID: 31626249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]